Skip to main content

Selected References

Selected References

  • Schmidt K., Harrer E.G., Tascilar K., Kubel S., El Kenz B., Hartmann F., Simon D., Schett G., Nganou-Makamdop K.*., Harrer T.*. (2022). Characterization of serum and mucosal SARS-CoV2 antibodies in HIV-1-infected subjects fter BNT162b2 mRNA vaccination or SARS-CoV-2 infection. Viruses, 14(3): 651. * Shared last author.
  • Nganou-Makamdop K.*, Talla A.*, Sharma A.S.*, Darko S., Ransier A., Laboune F., Chipman J.G., Beilman G.J., Hodskuldsson T., Fourati S., Schmidt T.E., Arumugam S., Lima N.S., Moon D., Callisto S., Schoephoerster J., Tomalka J., Mugyenyi P., Ssali F., Muloma P., Ssengendo P., Leda A.R., Cheu R.K., Flynn J.K., Morou A., Brunet-Ratnasingham E., Rodriguez B., Lederman M.M., Kaufmann D.E., Klatt N.R., Kityo C., Brenchley J.M., Schacker T.W., Sekaly R.P., Douek D.C. (2021). Translocated microbiome composition determines immunological outcome in treated HIV infection. Cell, 184(15): 3899-3914. e16. * Shared first author.
  • Shangguan S., Ehrenberg P.K., Geretz A., Yum L., Kundu G., May K., Fourati S., Nganou-Makamdop K., Williams L.D., Sawant S., Lewitus E., Pitisuttithum P., Nitayaphan S., Chariyalertsak S., Rerks-Ngarm S., Rolland M., Douek D.C., Gilbert P., Tomaras G.D., Michael N.L., Vasan S., Thomas R. (2021). Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1. Elife, 10: e69577. doi: 10.7554/eLife.69577.
  • Schmidt K.G., Nganou-Makamdop K., Tenbusch M., El Kenz B., Maier C., Lapuente D., Überla K., Spriewald B., Bergmann S., Harrer E.G., Harrer T. (2021). SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses. Front Immunol, 12: 627568.
  • Morou A., Brunet-Ratnasingham E., Dubé M., Charlebois R., Mercier E., Darko S., Brassard N., Nganou-Makamdop K., Arumugam S., Gendron-Lepage G., Yang L., Niessl J., Baxter A.E., Billingsley J.M., Rajakumar P.A., Lefebvre F., Johnson R.P., Tremblay C., Routy J.P., Wyatt R.T., Finzi A., Douek D.C., Kaufmann D.E. (2019). Altered differentiation is central to HIV-specific CD4+ T cell dysfunction in progressive disease. Nature Immunol, 20(8): 1059-1070.
  • Nganou-Makamdop K., Douek D.C. (2019). Manipulating the Interferon Signaling Pathway: Implications for HIV infection. Virologica Sinica, 34(2): 192-196.
  • Nganou-Makamdop K., Billingsley J.M., Yaffe Z., O'Connor G., Tharp G.K., Ransier A., Laboune F., Matus-Nicodemos R., Lerner A., Gharu L., Robertson J.M., Ford M.L., Schlapschy M., Kuhn N., Lensch A., Lifson J., Nason M., Skerra A., Schreiber G., Bosinger S.E., Douek D.C. (2018). Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication. PLoS Pathog, 14(8): e1007246.
  • Kityo C.*, Nganou Makamdop K.*, Rothenberger M., Chipman J.G., Hoskuldsson T., Beilman J.G., Grzywacz B., Mugyenyi P., Ssali F., Akondy R.S., Anderson J., Schmidt T., Reimann T., Callisto S., Schoephoerster J., Schuster J., Muloma N., Ssengendo P., Moysi E., Petrovas C., Lanciotti R., Zhang L., Arévalo M.T., Rodriguez B., Ross T.M., Trautmann L., Sekaly R.P., Lederman M.M., Koup R.A., Ahmed R., Reilly C., Douek D.C., Schacker T.W. (2018). Lymphoid tissue fibrosis is associated with impaired vaccine responses. J Clin Invest, 128(7): 2763-2773. * Shared first author.
  • Claiborne D.T., Prince J.L., Scully E., Macharia G., Micci L., Lawson B., Kopycinski J., Deymier M.J., Vanderford T.H., Nganou-Makamdop K., Ende Z., Brooks K., Tang J., Yu T., Lakhi S., Kilembe W., Silvestri G., Douek D., Goepfert P.A., Price M.A., Allen S.A., Paiardini M., Altfeld M., Gilmour J., Hunter E. (2015). Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad Sci U S A, 112(12): E1480-1489. doi: 10.1073/pnas.1421607112.
  • Sandler N.G., Bosinger S.E., Estes J.D., Zhu R.T., Tharp G.K., Boritz E., Levin D., Wijeyesinghe S., Makamdop K.N., del Prete G.Q., Hill B.J., Timmer J.K., Reiss E., Yarden G., Darko S., Contijoch E., Todd J.P., Silvestri G., Nason M., Norgren R.B. Jr, Keele B.F., Rao S., Langer J.A., Lifson J.D., Schreiber G., Douek D.C. (2014). Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature, 511(7511): 601-605.